Shares in Astrazeneca Pharma India Ltd fell as much as 5.02 per cent on profit-taking ahead of the company's board meet later in the day to consider a proposal by promoter AstraZeneca Pharmaceuticals AB (AZP AB) Sweden to delist the company.
Astrazenaca Pharma India has surged 47 per cent in the past 4 trading sessions on expectation that the delisting price would be at a substantial premium to the existing market price of the company.
Shares in the company were down 2.6 per cent at 11.30 a.m.
Copyright: Thomson Reuters 2014
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
